Halt Medical raises $5 million more to treat uterine fibroids
Livermore, Calif.-based Halt Medical tacked an additional $5 million onto a third round of financing — now totaling $17 million — to test a device that can remove uterine fibroids without a hysterectomy. The contribution came from American Capital Strategies, according to VentureWire.
Halt conducted clinical trials in Latin America earlier this year, but expects to kick off a new series of tests in the U.S. by February 2009. Its other investors include William Richter, cofounder… Continue Reading
Halt Medical, a uterine fibroids removal device co., raises $12
See David Hamilton’s story on this Pleasanton, Calif. company.
Halt Medical raises $12M for fibroids device
Halt Medical, a secretive Pleasanton, Calif., company, has raised $12 million in a third funding round as it prepares for human trials of a device designed to remove uterine fibroids without hysterectomy, VentureWire is reporting (subscription required).
Uterine fibroids — also sometimes known as fibromyomas, leiomyomas or myomas — are noncancerous growths of the uterus. Although generally not threatening to health, these fibroids can sometimes cause complications ranging from pain and heavy menstrual bleeding to backache,… Continue Reading